Curbstone Financial Management »

Halozyme Therapeutics shares owned by Curbstone Financial Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Curbstone Financial Management from 13F filings

Historical chart of Curbstone Financial Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Curbstone Financial Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Curbstone Financial Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $526k 8.2k 63.81
2024-09-30 $472k 8.2k 57.24
2024-06-30 $431k 8.2k 52.36

More positions owned by Curbstone Financial Management

SPDR Bloomberg Inter Floating Bdfund (FLRN)
Schwab International Equity ET Etf (SCHF)
SPDR S&P Mid Cap 400 ETF Etf (MDY)
Apple (AAPL)
Vanguard Short Ter Corp Bd ETF Bdfund (VCSH)
Vanguard S&P 500 ETF Etf (VOO)
Schwab US Large Cap Growth ETF Etf (SCHG)
Schwab US Mid Cap ETF Etf (SCHM)
Schwab US Dividend Equity ETF Etf (SCHD)
Alphabet Inc Class C cs (GOOG)
Microsoft Corporation (MSFT)
Vanguard Intermediate Corp ETF Bdfund (VCIT)
Schwab US Small Cap ETF Etf (SCHA)
Amazon (AMZN)
Schwab US Broad Mkt ETF Etf (SCHB)

View all positions for Curbstone Financial Management

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Arrowstreet Capital, Limited Partnership
Invesco
Snyder Capital Management
D. E. Shaw & Co
Geode Capital Management
Dimensional Fund Advisors
Alliancebernstein
Macquarie Group
Federated Investors
Hanna Zanoni
UBS Group
Two Sigma Investments

View all funds holding Halozyme Therapeutics